Unit

UNIT 4.4 Skin Allograft Rejection

  1. Amy S. Rosenberg

Published Online: 1 MAY 2001

DOI: 10.1002/0471142735.im0404s02

Current Protocols in Immunology

Current Protocols in Immunology

How to Cite

Rosenberg, A. S. 2001. Skin Allograft Rejection. Current Protocols in Immunology. 2:4.4:4.4.1–4.4.12.

Author Information

  1. Food and Drug Administration, Bethesda, Maryland

Publication History

  1. Published Online: 1 MAY 2001
  2. Published Print: JUN 1992

This is not the most recent version of the article. View current version (1 FEB 2009)

Abstract

Skin allograft rejection is a test of the competence of T lymphocytes to mediate in vivo tissue destruction, which in turn reflects their role in critical functions such as anti-viral and tumor immunity. The tail-skin graft procedure described here is useful predominantly because of the ease of preparation and resistance to ischemic (nonspecific) necrosis. Additionally, it is not necessary to sacrifice the donor mouse. However, rejection of tail-skin grafts should not be used to test for genetic homogeneity in breeding experiments or to detect minor histocompatibility (minor-H) antigens because tail skin is less sensitive than trunk skin in detecting such differences. The trunk-skin graft procedure detailed here more difficult to perform than the tail-skin graft. It requires extensive tissue preparation and is more susceptible to ischemic necrosis. Trunk-skin grafts are especially useful for detecting minimal histocompatibility differences.